Seractide
Drug profile
Also known as: acthar gel-synthetic, seractide acetate, seractide acetate hydrate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Seractide is a drug catalogued in DrugCentral. It was first approved by the FDA in 1978. DrugCentral lists 1 molecular target, including MC2R.
- Molecular targets: MC2R (1 listed in DrugCentral).
- Molecular formula: C207H308N56O58S; molecular weight 4541.14 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Adrenocorticotropic hormone receptor | MC2R | agonist | Ki 8.01 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1978-02-21 | FDA | — | ARMOUR PHARM |
Chemical structure
| Molecular formula | C207H308N56O58S |
|---|---|
| Molecular weight | 4541.14 g/mol |
| CAS number | — |
| InChIKey | FHOCOBKCNJYXOP-OVLDLUHVSA-N |
| PubChem CID | 90488848 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Seractide work?
Its molecular targets in DrugCentral include MC2R (agonist).
When was Seractide first approved?
Seractide was first approved by the FDA in 1978.
What is the chemical formula of Seractide?
Seractide has the molecular formula C207H308N56O58S and a molecular weight of 4541.14 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4821 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1201489 — compound record and bioactivity
- PubChem CID 90488848 — chemical identifiers
- DrugBank DB09334 — drug record
- FDA UNII IGM44CEY2I — substance identity
- DailyMed: FDA labels for Seractide — current prescribing information (label search)
- UniProt Q01718 (MC2R) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.